BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 26238155)

  • 21. Expression pattern of parkin isoforms in lung adenocarcinomas.
    D'Amico AG; Maugeri G; Magro G; Salvatorelli L; Drago F; D'Agata V
    Tumour Biol; 2015 Jul; 36(7):5133-41. PubMed ID: 25656612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.
    Yeo CW; Ng FS; Chai C; Tan JM; Koh GR; Chong YK; Koh LW; Foong CS; Sandanaraj E; Holbrook JD; Ang BT; Takahashi R; Tang C; Lim KL
    Cancer Res; 2012 May; 72(10):2543-53. PubMed ID: 22431710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
    Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
    Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.
    La Cognata V; Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Biochem; 2018 Jan; 119(1):1062-1073. PubMed ID: 28688199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
    He S; Deng J; Li G; Wang B; Cao Y; Tu Y
    Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profile of parkin isoforms in human gliomas.
    Maugeri G; D'Amico AG; Magro G; Salvatorelli L; Barbagallo GM; Saccone S; Drago F; Cavallaro S; D'Agata V
    Int J Oncol; 2015 Oct; 47(4):1282-92. PubMed ID: 26238155
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.